AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novel Coronavirus Treatment

844.007

-3.432-0.40%

Number of Gainers:9

Number of Losers:9

Number of Flat:14

PE:- -

High:851.010

Open:849.498

Low:840.770

Close:847.439

Volume:25.42M

Turnover:230.89M

Market Cap:214.57B

Float Cap:169.36B

Loading ...

Should I invest $5,000 in Coles shares now?

Is American Tower (AMT) Pricing Reflecting DCF And P/E Signals After REIT Rate Jitters

Simply Wall St.

Mesoblast Director Philip James Facchina Files Initial Beneficial Ownership Statement

Mesoblast director Jane Catherine Bell files Form 3 initial beneficial ownership statement

Mesoblast names CFO James Michael O’Brien in initial beneficial ownership filing

Mesoblast names Chief Medical Officer and Director Eric Allen Rose in initial beneficial ownership filing

CSL Finance Gets Board Nod to Raise Up To INR1.50 Billion Through Debenture Issue

MT Newswires Live

3 reasons to buy CSL shares today

New Zealand Supermarkets Receive Notice From Grocery Commissioner

MT Newswires Live

Woolworths shares are storming ahead of Coles this year: Are the supermarket giants a buy, sell, or hold?

ASX Midday Sector Update: Utilities Sector Advances, Consumer Staples Struggle

MT Newswires Live

With global populations ageing, are ResMed shares a good buy today?

NZX Midday Sector Update: Consumer Durables Sector Soars, Health Technology Sector Struggles

MT Newswires Live

CSL Faces Temporary Supply Shortage of Hemophilia B Gene Therapy

MT Newswires Live

Why Cochlear and ResMed shares could be strong buys

Mesoblast to host inaugural R&D Day webcast

3 ASX ETFs to weather market turmoil

These 2 blue-chip ASX stocks will suffer from high oil prices

CSL flags global stockout of bleeding disorder gene therapy

BRIEF-CSL Currently Experiencing Temporary Global Stockout Of HEMGENIX

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK7501/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7501","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","market":"AU","secType":"PLATE","nameCN":"Novel Coronavirus Treatment","latestPrice":844.00745,"timestamp":1773809999898,"preClose":847.4393,"halted":0,"volume":25419624,"delay":0,"changeRate":-0.00405,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-3.431824,"latestTime":"03-18 16:00:00 AEDT","open":849.49805,"high":851.0097,"low":840.76984,"amount":230891855,"amplitude":0.012083,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1773874800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1773788400000,1773810000000]],"turnoverRate":0.00177,"increases":9,"decrements":11,"flats":12,"marketCap":214567572773.5,"floatMarketCap":169355117926.71094},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7501\",,,,,undefined,":{"symbol":"BK7501","high":851.0097,"amplitude":0.012083,"preClose":847.4393,"low":840.76984,"latestPrice":844.00745,"volume":25419624,"delay":0,"open":849.49805,"prevYearClose":900.1661,"prevWeekClose":844.972,"prevMonthClose":875.89,"prevQuarterClose":900.166,"fiveDayClose":849.352,"twentyDayClose":868.178,"sixtyDayClose":904.617,"secType":"PLATE","market":"AU","turnoverRate":0.00177,"marketCap":214567572773.5,"floatMarketCap":169355117926.71094,"timestamp":1773809999898,"nameCN":"Novel Coronavirus Treatment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7501\",,,,undefined,":{"bkCode":"BK7501","up":9,"down":9,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7501\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2620501972","title":"Should I invest $5,000 in Coles shares now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620501972","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620501972?lang=en_us&edition=fundamental","pubTime":"2026-03-18 23:30","pubTimestamp":1773847800,"startTime":"0","endTime":"0","summary":"I'd be comfortable investing $5,000 in Coles shares today. This is because I think it offers a combination of a more attractive entry point, reliable, fully-franked income, a defensive business model, and ongoing operational improvements.  Overall, it's the kind of stock I'd be comfortable owning through different market conditions. Foolish Takeaway Coles shares aren't likely to double overnight. That's not the point. At around 13.5% below their recent high, offering steady dividends and backed by a resilient business, I think they're a solid option for a $5,000 investment today.  For me, it's a reminder that sometimes the best opportunities aren't the most exciting ones.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/19/should-i-invest-5000-in-coles-shares-now/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/19/should-i-invest-5000-in-coles-shares-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7082","BK7040","COL.AU"],"gpt_icon":0},{"id":"2620257063","title":"Is American Tower (AMT) Pricing Reflecting DCF And P/E Signals After REIT Rate Jitters","url":"https://stock-news.laohu8.com/highlight/detail?id=2620257063","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620257063?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:11","pubTimestamp":1773843079,"startTime":"0","endTime":"0","summary":"If you are trying to work out whether American Tower is attractively priced or not, the recent share performance gives you a useful starting point but not the full story.\nThe stock last closed at US$185.07, with returns of a 0.6% decline over 7 days, a 3.7% decline over 30 days, a 5.9% gain year to date, and a 10.8% decline over 1 year.\nRecent headlines have focused on American Tower as a key player in listed real estate focused on telecom infrastructure, alongside ongoing attention on...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/24766-main-header/1756252641913"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/is-american-tower-amt-pricing-reflecting-dcf-and-pe-signals","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-amt/american-tower/news/is-american-tower-amt-pricing-reflecting-dcf-and-pe-signals","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7007","BK4219","8C8U.SI","BK4554","AMT.AU","BK4585","BK4588","BK6142","CFA.SI","AMT","BK4581","BK7501","REIT","BK4534","DCF","BK4084"],"gpt_icon":0},{"id":"2620251603","title":"Mesoblast Director Philip James Facchina Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620251603","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620251603?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:41","pubTimestamp":1773841317,"startTime":"0","endTime":"0","summary":"Philip James Facchina, a director of Mesoblast, filed an initial statement of beneficial ownership. The filing reported 123,220 ordinary shares held indirectly through HNP. It also listed director-held options covering 66,667 ordinary shares at an exercise price of AUD 2.26. Additional director-held options covered 96,811 ordinary shares at an exercise price of AUD 0.36. The filing reported indirect warrants through HNP for 68,306 ordinary shares at an exercise price of AUD 2.86.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5ctL40:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","MSB.AU"],"gpt_icon":0},{"id":"2620251643","title":"Mesoblast director Jane Catherine Bell files Form 3 initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620251643","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620251643?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:40","pubTimestamp":1773841238,"startTime":"0","endTime":"0","summary":"Mesoblast director Jane Catherine Bell filed an initial statement of beneficial ownership. The filing reported 622,492 ordinary shares held indirectly via a self-managed superannuation fund. It also reported stock options to buy ordinary shares totaling 719,037 shares. The options carried exercise prices of AUD 0.36, AUD 0.83, and AUD 0.97.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL5m0b48:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7067","MSB.AU"],"gpt_icon":0},{"id":"2620251342","title":"Mesoblast names CFO James Michael O’Brien in initial beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620251342","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620251342?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:35","pubTimestamp":1773840949,"startTime":"0","endTime":"0","summary":"Mesoblast reported an initial statement of beneficial ownership by James Michael O'Brien, its Chief Financial Officer. The filing stated that O'Brien beneficially owned no Mesoblast securities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL64jXpp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7501","BK7508","BK7067"],"gpt_icon":0},{"id":"2620251348","title":"Mesoblast names Chief Medical Officer and Director Eric Allen Rose in initial beneficial ownership filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2620251348","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620251348?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:35","pubTimestamp":1773840903,"startTime":"0","endTime":"0","summary":"Mesoblast reported that Eric Allen Rose filed an initial statement of beneficial ownership as Chief Medical Officer and director. Rose reported direct ownership of 6,749,274 ordinary shares. He also reported options to buy 6,416,519 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3HwLLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","MSB.AU","BK7508"],"gpt_icon":0},{"id":"2620234200","title":"CSL Finance Gets Board Nod to Raise Up To INR1.50 Billion Through Debenture Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2620234200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620234200?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:24","pubTimestamp":1773829457,"startTime":"0","endTime":"0","summary":"CSL Finance  has received board approval to raise up to 1.50 billion Indian rupees through the issue of non-convertible debentures on a private placement basis, according to a Wednesday filing to the Indian stock exchanges.The company plans to issue various types of debentures in one or more tranches, details of which will be decided by the board.The debentures are proposed to be listed on the BSE.The company's shares are up nearly 1% in recent trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","BK7501","BK7067","BK7508","SG9999004303.SGD","BK7511","SGXZ23171101.USD","CSL","CSL.AU","LU0728928796.USD","BK4086","LU1169590202.USD"],"gpt_icon":0},{"id":"2620301286","title":"3 reasons to buy CSL shares today","url":"https://stock-news.laohu8.com/highlight/detail?id=2620301286","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620301286?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:57","pubTimestamp":1773806278,"startTime":"0","endTime":"0","summary":"CSL Ltd (ASX: CSL) shares are down 1.4% in Wednesday afternoon trade. At the time of writing, the beaten-down biotech stock is trading at $139.13 per share.  Today's decline means the shares are now d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/3-reasons-to-buy-csl-shares-today-3/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/3-reasons-to-buy-csl-shares-today-3/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7511","BK7508","LU1169590202.USD","LU0728928796.USD","CSL.AU","BK4086","LU1169589451.USD","CSL","BK7067","SGXZ23171101.USD","SG9999004303.SGD"],"gpt_icon":0},{"id":"2620863662","title":"New Zealand Supermarkets Receive Notice From Grocery Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2620863662","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620863662?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:53","pubTimestamp":1773805988,"startTime":"0","endTime":"0","summary":"New Zealand Grocery Commissioner Pierre Heerden said he has put supermarkets on notice that they should not seek additional margin from rising costs linked to the Middle East conflict, and that any price increases should be reversed as soon as possible, according to a Wednesday RNZ report.Heerden said supermarkets had indicated that the additional costs had not yet been passed on to consumers, though he cautioned that this would depend on how long the conflict continued, the report added.Gemma Rasmussen, Consumer NZ's head of advocacy, said that New Zealand should consider an excessive pricing regime similar to one in Australia, which would cap supermarket markups and impose penalties of up to AU$10 million for breaches.Shares of Woolworths Group , which has operations in New Zealand, were marginally higher in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ50G.NZ","BK7501","NZ20C.NZ","T10G.NZ","WOW.AU","BK7040","BK7511"],"gpt_icon":0},{"id":"2620285020","title":"Woolworths shares are storming ahead of Coles this year: Are the supermarket giants a buy, sell, or hold?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620285020","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620285020?lang=en_us&edition=fundamental","pubTime":"2026-03-18 11:44","pubTimestamp":1773805458,"startTime":"0","endTime":"0","summary":"Supermarket giants Woolworths Group Ltd  and Coles Group Ltd  have had a rivalry spanning decades. From grocery prices to product lines, revenue growth, and even share prices, the two retailers compete for nearly everything with Australia's supermarket and grocery retail sector.Shares of both supermarkets have been neck and neck for some time, but so far in 2026, Woolworths is storming ahead.Coles shares are down 0.3% at the time of writing, to $21 a piece. It's been a pretty volatile start to 2026 for the supermarket giant, with its share price wildly fluctuating. The share price is now down 1.7% for the year to date and 13% higher over the past year.Unlike Woolworths, Coles' growth strategy paid off late last year. The retailer experienced a surge in its value in 2025, particularly following its FY25 results announcement in August.But analysts generally expect Coles to recover through 2026 after its strategic cost-saving initiatives begin to flow through to its financials.Despite the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/woolworths-shares-are-storming-ahead-of-coles-this-year-are-the-supermarket-giants-a-buy-sell-or-hold/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/woolworths-shares-are-storming-ahead-of-coles-this-year-are-the-supermarket-giants-a-buy-sell-or-hold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7082","WOW.AU","BK7511","BK7040","COL.AU","EBIT"],"gpt_icon":0},{"id":"2620288377","title":"ASX Midday Sector Update: Utilities Sector Advances, Consumer Staples Struggle","url":"https://stock-news.laohu8.com/highlight/detail?id=2620288377","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620288377?lang=en_us&edition=fundamental","pubTime":"2026-03-18 10:07","pubTimestamp":1773799626,"startTime":"0","endTime":"0","summary":"The utilities sector advanced more than 1% at midday on Wednesday.Origin Energy (ASX:ORG) shares gained more than 1% in recent trade.Meanwhile, consumer staples stocks struggled, falling marginally.Woolworths (ASX:WOW) and Coles (ASX:COL) shares inched down in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7511","COL.AU","BK7130","BK7507","BK7082","BK7040","BK7006","WOW.AU","ORG.AU"],"gpt_icon":0},{"id":"2620266400","title":"With global populations ageing, are ResMed shares a good buy today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2620266400","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620266400?lang=en_us&edition=fundamental","pubTime":"2026-03-18 09:51","pubTimestamp":1773798676,"startTime":"0","endTime":"0","summary":"Securities Vault's Nathan Lodge recently ran his slide rule over the ASX 200 healthcare stock . \"ResMed remains a global leader in sleep apnoea devices and digital health monitoring,\" Lodge noted. And ResMed shares look well-placed to deliver long-term growth. \"Structural demand drivers, including ageing populations, increasing diagnosis rates and broader awareness of sleep health, continue to support long term growth,\" Lodge said. But he's not ready to pull the trigger just yet. Explaining his hold recommendation on ResMed shares, Lodge concluded: However, a strong share price recovery following concerns about the impact of weight loss drugs on sleep apnoea treatment appears to leave much of the near-term optimism priced into the stock. While the company's fundamentals remain robust, the valuation reflects its market leadership and growth outlook. Investors may prefer to retain existing positions, while awaiting further earnings expansion, or more attractive entry points. What's the l","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/with-global-populations-ageing-are-resmed-shares-a-good-buy-today/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/with-global-populations-ageing-are-resmed-shares-a-good-buy-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2177674079.SGD","BK7501","RMD","LU2008162690.USD","BK4585","BK4504","XJO.AU","BK4588","LU0170899867.USD","BK7007","RMD.AU","BK4082","BK4567","BK4548","IE00B5TLWC47.USD"],"gpt_icon":0},{"id":"2620040731","title":"NZX Midday Sector Update: Consumer Durables Sector Soars, Health Technology Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2620040731","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620040731?lang=en_us&edition=fundamental","pubTime":"2026-03-18 09:04","pubTimestamp":1773795856,"startTime":"0","endTime":"0","summary":"The consumer durables shares gained the most on New Zealand's Exchange, rising nearly 8% on Wednesday.Shares of KMD Brands  rose 5% in recent trade.On the flip side, the health technology sector struggled, shedding almost 1%.Shares of Fisher & Paykel Healthcare  fell past 1% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","T10G.NZ","FPH.AU","NZ20C.NZ","KMD.AU","BK7128","BK8020","BK8004","NZX.NZ","BK7007","FPH.NZ","NZ50G.NZ"],"gpt_icon":0},{"id":"2620021234","title":"CSL Faces Temporary Supply Shortage of Hemophilia B Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620021234","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620021234?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:41","pubTimestamp":1773794487,"startTime":"0","endTime":"0","summary":"CSL  said it is experiencing a temporary global shortage of its one-time gene therapy infusion, Hemgenix, also known as etranacogene dezaparvovec-drlb, which may delay treatment for some patients in countries with commercial access, the biotechnology company said in a statement on Wednesday.The company emphasizes that this issue is not related to safety or effectiveness but rather highlights the complexity of manufacturing gene therapies while upholding the highest regulatory and quality standards.The company said it is working with authorities to stabilize supply and ensure eligible individuals have timely access and information.The company's shares fell around 1% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4086","BK7508","LU1169590202.USD","BK7501","LU1169589451.USD","SG9999004303.SGD","CSL","LU0728928796.USD","CSL.AU","SGXZ23171101.USD","BK7067","BK7511"],"gpt_icon":0},{"id":"2620402124","title":"Why Cochlear and ResMed shares could be strong buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2620402124","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620402124?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:39","pubTimestamp":1773794353,"startTime":"0","endTime":"0","summary":"If you want exposure to the healthcare sector, then it could be worth hearing what Wilsons is saying. That's because the broker recently named the two popular ASX healthcare shares in this article as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/why-cochlear-and-resmed-shares-could-be-strong-buys/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/why-cochlear-and-resmed-shares-could-be-strong-buys/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2177674079.SGD","RMD.AU","BK7007","BK7501","RMD","BK4504","BK4567","BK4588","COH.AU","LU0170899867.USD","BK4082","BK4548","LU2008162690.USD","IE00B5TLWC47.USD","BK4585"],"gpt_icon":0},{"id":"2620401554","title":"Mesoblast to host inaugural R&D Day webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2620401554","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620401554?lang=en_us&edition=fundamental","pubTime":"2026-03-18 07:20","pubTimestamp":1773789612,"startTime":"0","endTime":"0","summary":"Mesoblast will host an R&D Day on April 8, 2026 in New York City. The event is scheduled to run from 8:00am to 11:00am EST and will be webcast. The webcast link is .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL6HbfW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK7067","NDAQ","IE00BKPKM429.USD","BK4585","SG9999014039.USD","MSB.AU","SG9999014021.USD","BK7508","LU2095319765.USD","BK7501","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2W23.USD","LU2210150020.SGD","BK4588","LU0314104364.USD","SG9999014013.SGD","SG9999014005.SGD","BK4112","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2620470498","title":"3 ASX ETFs to weather market turmoil","url":"https://stock-news.laohu8.com/highlight/detail?id=2620470498","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620470498?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:45","pubTimestamp":1773776700,"startTime":"0","endTime":"0","summary":"ASX ETFs can be a simple way to navigate market volatility. When markets turn turbulent, many investors panic. But history shows downturns often create some of the best long-term opportunities. Instea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/3-asx-etfs-to-weather-market-turmoil/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/3-asx-etfs-to-weather-market-turmoil/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1623119135.USD","LU2237443978.SGD","LU0912757837.SGD","LU0444973449.USD","LU2471134523.USD","LU0302445910.USD","BK4550","LU0354030511.USD","LU1934455277.USD","LU0957791311.USD","MSFL","LU2125909593.SGD","LU2471134952.CNY","LU0079474960.USD","LU0971096721.USD","BK4598","LU2491050154.USD","LU0417517546.SGD","LU0965509010.AUD","GB00B4QBRK32.GBP","LU0871640123.AUD","LU0868494617.USD","LU2087621335.USD","IE00BYXW3230.USD","LU0689626769.HKD","LU2237957902.USD","LU1196500208.SGD","BK7095","LU2592432038.USD","LU2065169927.USD","LU2361044865.SGD","LU2506952170.USD","IE0004086264.USD","LU0266013472.USD","LU0823421333.USD","LU0964807845.USD","LU0211328371.USD","LU1629891620.HKD","LU0094547139.USD","LU1935043023.USD","IE00BMPRXR70.SGD","LU1934455194.USD","LU2362541513.USD","LU1718418525.SGD","LU1935043536.SGD","IE00B19Z9505.USD","LU2430703095.HKD","LU0965509283.SGD","LU0345768740.USD","LU1323610961.USD","LU0879622024.SGD","SG9999018865.SGD","IE00BBT3K403.USD","LU1951200564.SGD","LU2360106780.USD","LU0823421416.USD","LU2552382215.SGD","HK0000914686.HKD","LU1145028129.USD","IE0034235188.USD","LU1003077747.HKD","LU0210528500.USD","LU2433249047.HKD","SG9999014906.USD","BK4227","LU0690374615.EUR","LU2298321311.HKD","SG9999014898.SGD","LU0345770308.USD","LU0203201768.USD","LU0225283273.USD","IE00BN29S564.USD","BK4581","LU1989772923.USD","LU0823434740.USD","BK4566","LU1244550494.USD","LU0642271901.SGD","IE0005OL40V9.USD","LU1064131342.USD","BK4097","LU2764263039.SGD","MSFU","LU2471134796.USD","LU1642822529.SGD","IE0009G5SDU7.USD","IE00BFSS7M15.SGD","LU0289960550.SGD","LU0994945656.USD","IE00BKPKM429.USD","LU0053666078.USD","LU0426417589.USD","SG9999015986.USD","LU2236285917.USD","LU1674673428.USD","LU0289941410.SGD","LU2237443549.SGD","IE00BQXX3F31.USD","LU2191332357.HKD","BK4592","LU2065170008.USD","LU2461242641.AUD","LU2092937221.SGD","LU2211815571.USD","SG9999001077.SGD","LU2543165471.USD","LU1582986359.USD","LU1935042488.USD","LU0061474960.USD","LU1066051811.HKD","LU1720051108.HKD","LU1074936037.SGD","MOAT.AU","LU0029864427.USD","LU0861579265.USD","LU1839511570.USD","LU0109391861.USD","LU2244417387.USD","LU1633808545.USD","LU1917777945.USD","BK4588","IE00BFSS8Q28.SGD","LU2210149790.SGD","SGXZ81514606.USD","LU0158827948.USD","LU0494093205.USD","SG9999002232.USD","SG9999014567.USD","BK4532","LU2413666699.HKD","LU1815333072.USD","LU2125154935.USD","LU2417539215.USD","LU1670711040.USD","LU0661504455.SGD","LU1244550221.USD","LU1720051017.SGD","LU1046421795.USD","LU1815336760.USD","LU1334329650.SGD","LU2237438978.USD","LU0553294199.USD","LU0170899867.USD","GB00BDT5M118.USD","LU1791710582.SGD","LU0289739343.SGD","LU0107464264.USD","LU1670710588.SGD","LU1670711123.USD","MSFW","LU0096364046.USD","LU0342679015.USD","LU2087625088.SGD","LU1861217088.USD","LU2250418816.HKD","LU1235294995.USD","BK7042","IE00BQXX3D17.EUR","LU2264538146.SGD","IE0009356076.USD","LU0106261372.USD","LU0868494708.USD","LU0354030438.USD","LU1363072403.SGD","LU0157215616.USD","LU0456855351.SGD","LU2279689827.SGD","LU0314104364.USD","LU0823434583.USD","LU2063271972.USD","BK4504","LU0353189763.USD","IE00B5949003.HKD","LU1121112475.USD","LU2487616109.SGD","IE00BMPRXQ63.HKD","LU2168564222.USD","LU0162691827.USD","LU2242650005.HKD","LU0965508806.USD","LU0689472784.USD","LU0203202063.USD","SG9999017495.SGD","LU2054465674.USD","LU2111349929.HKD","IE0034235303.USD","LU0316494557.USD","LU0348723411.USD","LU2756315664.SGD","LU1316542783.SGD","LU2471134879.HKD","LU1670756490.USD","LU1645745479.HKD","LU0466842654.USD","LU0061474705.USD","LU1035773651.USD","LU1435385759.SGD","LU1119994496.HKD","LU0187121727.USD","LU0251132253.USD","LU2347655073.USD","LU0072461881.USD","LU1814569148.SGD","IE00BKDWB100.SGD","LU2089284900.SGD","IE00B19Z8X17.USD","MSFX","LU1228905037.USD","LU1951198990.SGD","LU0557290698.USD","LU0949170772.SGD","LU1280957306.USD","LU1430594728.SGD","LU2125909247.SGD","LU1221951046.USD","IE0004445015.USD","LU1400636574.HKD","MSFO","LU2213496289.HKD","LU0345769128.USD","SG9999014542.SGD","IE0003U64NQ7.SGD","LU0310799852.SGD","LU0426412945.USD","LU2750360641.GBP","LU1721428933.USD","LU1732800096.USD","LU0390134368.USD","LU2242649171.HKD","LU0823417737.USD","LU0256863902.USD","LU2361044949.HKD","LU2097829019.USD","BK4538","IE00BYQQ9H92.USD","IE00B7KXQ091.USD","GB00B4LPDJ14.GBP","LU1032955483.USD","LU2357305700.SGD","SG9999015358.SGD","LU1043141123.HKD","LU2023251221.USD","BK4528","LU1852331112.SGD","LU1670710661.SGD","LU2896262040.SGD","BK4503","MSFD","LU2237443465.HKD","LU1564329461.SGD","LU2720916845.USD","LU0127658192.USD","IE00B3SWFQ91.USD","BK4554","LU2506951875.HKD","LU2023250504.SGD","LU1564329115.USD","LU2458330243.SGD","BK4576","LU2750360997.AUD","LU1188199696.SGD","LU1804176565.USD","LU1059921491.USD","LU2065171311.SGD","LU1868837300.USD","LU0323240290.USD","LU2452424414.USD","LU2023250330.USD","LU0792757196.USD","IE00BLSP4452.SGD","LU0787776722.HKD","LU0476273544.USD","LU1803068623.USD","LU1861127337.USD","LU0726765562.USD","LU0820561818.USD","LU0081259029.USD","BK4612","LU1116320901.HKD","LU0347712357.USD","LU0960925559.SGD","LU2746668461.USD","LU0882574139.USD","LU2125154778.USD","LU0011850046.USD","LU2458330169.SGD","LU2552382058.USD","LU2097344357.USD","IE000ITXATA3.USD","LU0757359954.USD","LU2041044095.USD","LU0795875169.SGD","IE00BZ1G4Q59.USD","LU0943347566.SGD","LU0985320562.USD","SG9999015978.USD","LU2430703178.SGD","LU1235295455.SGD","IE00BK4W5M84.HKD","LU0057025933.USD","LU1043141396.HKD","IE00BDRTCR15.USD","SG9999014559.SGD","IE00BJTD4V19.USD","LU2381873111.SGD","LU2506952097.USD","BK4525","LU2237957811.SGD","LU1670628061.USD","IE00BQXX3C00.GBP","LU0072462426.USD","LU0198837287.USD","LU2133065610.SGD","LU2028103732.USD","BK4548","BK7508","LU0472753341.HKD","LU2430703251.USD","LU0061475181.USD","LU1066051498.USD","LU1548497426.USD","LU1035775433.USD","LU1236620750.USD","LU0096362180.USD","LU1974910355.USD","LU2271345857.HKD","IE00B1BXHZ80.USD","LU0823417653.USD","LU2602419157.SGD","SG9999001424.SGD","SG9999014575.USD","LU0820561909.HKD","IE00BFXG0V08.USD","IE00BMPRXN33.USD","LU1923622614.USD","LU0320765059.SGD","LU2106854487.HKD","LU2237443382.USD","LU0795875086.SGD","LU1697837992.HKD","SG9999002224.SGD","LU0528227936.USD","LU2360108059.USD","LU1989763005.USD","IE00BLSP4239.USD","IE000YTNTUN2.SGD","LU1400636657.SGD","LU0069063385.USD","LU1989764664.SGD","IE000KEQY171.SGD","LU1582987597.SGD","LU1989764748.USD","BK4543","LU1116320737.USD","LU1228905540.USD","LU1582986433.USD","LU2092627202.USD","SG9999015341.SGD","IE00BDCRKT87.USD","LU2108987350.USD","BK4534","BK7507","LU0788109477.HKD","LU0154236417.USD","LU1564329628.SGD","LU1066051225.USD","BK4533","SG9999014880.SGD","LU0708994859.HKD","LU2247934214.USD","SG9999004303.SGD","LU0511384066.AUD","LU0784384876.USD","LU0265550946.USD","LU1823568750.SGD","LU0353189680.USD","LU1585245621.USD","LU1868836757.USD","LU2023250843.SGD","LU2168563687.JPY","LU1989772840.SGD","LU0048584097.USD","LU2360107671.USD","LU0738911758.USD","LU0950375773.USD","LU0690374961.EUR","LU0323239441.USD","IE00BKVL7J92.USD","LU0965509101.SGD","IE0001KFT4U8.USD","LU1564329032.USD","BK4106","LU0234572021.USD","LU0276348264.USD","LU0444971666.USD","LU1670627923.USD","LU1261432733.SGD","LU2210150020.SGD","LU0171293334.USD","LU2168564149.EUR","LU0683600562.USD","LU2505996681.GBP","LU0889565833.HKD","LU2275660780.HKD","IE00B19Z8W00.USD","BK7067","LU0784385840.USD","IE00B3S45H60.SGD","LU0784383803.USD","LU2462157665.USD","LU1429558221.USD","LU2326559502.SGD","LU2456880835.USD","LU1712237335.SGD","LU0784385170.HKD","LU2148611432.USD","LU0256863811.USD","LU1236620834.HKD","LU0080751232.USD","IE00B4JS1V06.HKD","LU0894485498.HKD","LU2756315318.SGD","LU1069347547.HKD","LU2506951958.HKD","LU1506573853.SGD","LU0345774391.USD","LU2860962120.EUR","LU0308772762.SGD","LU1267930490.SGD","LU1868836591.USD","HK0000914660.USD","LU0889566641.SGD","LU1868837136.USD","LU2463028550.USD","LU2746668974.SGD","SG9999018857.SGD","LU1868836914.USD","LU1674673691.USD","LU0056508442.USD","SG9999015952.SGD","LU2065171402.SGD","LU1496350502.SGD","LU1037948897.HKD","LU2361045086.USD","LU2092937148.SGD","IE00BSNM7G36.USD","LU2168564065.EUR","LU2265009873.SGD","LU0957808578.USD","BK4567","LU0545562505.USD","SG9999015945.SGD","LU1301847155.USD","LU0545039389.USD","LU0215105999.USD","MSFY","LU0265550359.USD","LU1127390331.HKD","LU2552382132.HKD","LU2362541273.HKD","LU0312595415.SGD","LU2097344431.USD","LU2505996509.AUD","LU0211327993.USD","LU0708995401.HKD","LU0640476718.USD","LU0234570918.USD","BK4579","LU0095938881.EUR","LU1935042991.SGD","LU0210533765.USD","LU2420271590.USD","LU1181866309.USD","LU1340139317.AUD","BK4577","IE00BK4W5L77.USD","LU0672654240.SGD","LU2347655156.SGD","BK4516","LU0942090050.USD","LU0345774631.USD","LU0082616367.USD","IE00B5TLWC47.USD","LU0149725797.USD","LU0757359368.USD","LU0070217475.USD","LU0238689110.USD","LU0894486033.HKD","LU2491049909.HKD","LU1691799644.USD","LU1732799900.SGD","IE000W1ABFV2.USD","LU1582987324.SGD","IE00BJLML261.HKD","LU1267930730.SGD","LU2237443895.HKD","LU2077746001.SGD","LU2089283258.USD","LU1037948541.HKD","LU1366333091.USD","LU1551013425.SGD","BK7135","SGXZ23171101.USD","LU2237443622.USD","LU0323591593.USD","SG9999014914.USD","LU1496350171.SGD","LU2764263203.CNY","LU1934455863.HKD","LU1066053197.SGD","LU0128525929.USD","LU0345770993.USD","LU1267930573.SGD","LU2360032135.SGD","LU1366192091.USD","LU1400636491.USD","IE0034235295.USD","LU0109392836.USD","IE0004445239.USD","IE00BJJMRX11.SGD","LU0267386448.USD","LU0175139822.USD","LU1571399168.USD","LU1084165304.USD","SGXZ99366536.SGD","LU1923623000.USD","BK7501","LU1778281490.HKD","BK7511","BK4585","IE00BJTD4N35.SGD","LU2413666426.HKD","LU0949170426.SGD","LU1069344957.HKD","LU1232071149.USD","LU2286300806.USD","SGXZ31699556.SGD","LU2168564495.EUR","LU1202635105.USD","LU0719512351.SGD","BK4535","SG9999000418.SGD","LU0314106906.USD","BK4527","LU0310800379.SGD","LU1988902786.USD","LU2095319765.USD","LU0006306889.USD","IE00B4YYXB79.USD","LU1267930813.SGD","LU1032466523.USD","LU1791710400.SGD","LU1803068979.SGD","SYI.AU","LU1221951129.SGD","LU0724617625.USD","LU2403377893.USD","LU1153585028.USD","LU2764262908.HKD","LU2362540622.SGD","IE0004091025.USD","VAS.AU","IE00B775H168.HKD","LU0097036916.USD","IE00B775SV38.USD","LU1861220207.SGD","LU1935042215.USD","BK4559","IE00BHPRN162.USD","LU2404859741.USD","LU0158827781.USD","LU2491050071.SGD","BK4587","LU0210536198.USD","IE00BJJMRY28.SGD","LU2404859667.USD","IE00BN8TJ469.HKD","IE00BWXC8680.SGD","LU2083900584.USD","SGXZ51526630.SGD","LU0124676726.USD","LU1983260115.SGD","LU0077335932.USD","LU0820562030.AUD","LU0289961442.SGD","LU0345769631.USD","LU1551013342.USD","LU1989773731.SGD","LU0345768153.USD","LU1244550577.SGD","IE00B1XK9C88.USD","LU1914381329.SGD"],"gpt_icon":0},{"id":"2620470617","title":"These 2 blue-chip ASX stocks will suffer from high oil prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2620470617","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620470617?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:30","pubTimestamp":1773775800,"startTime":"0","endTime":"0","summary":"As you would probably be aware of by now, the US-Iran war has resulted in a dramatic spike in oil prices. Thanks to the closure of the Strait of Hormuz, a vital shipping artery for the world's energy ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"motleyfoolau_stock","url":"https://www.fool.com.au/2026/03/18/these-2-blue-chip-asx-stocks-will-suffer-from-high-oil-prices/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2026/03/18/these-2-blue-chip-asx-stocks-will-suffer-from-high-oil-prices/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4588","BK4535","BK7090","TCL.AU","BK7501","BK4570","BK4585","BK7511","BK7040","WOW.AU"],"gpt_icon":1},{"id":"2620339471","title":"CSL flags global stockout of bleeding disorder gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2620339471","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620339471?lang=en_us&edition=fundamental","pubTime":"2026-03-18 00:36","pubTimestamp":1773765411,"startTime":"0","endTime":"0","summary":"CSL flags global stockout of bleeding disorder gene therapyBy Sahil  Pandey","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL4N4051IX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234572021.USD","BK4533","IE00BBT3K403.USD","LU1057294990.SGD","BK7501","LU0170899867.USD","LU0321505439.SGD","SG9999001176.SGD","SG9999011175.SGD","SG9999001176.USD","LU0225284248.USD","LU0868494617.USD","CSL.AU","IE00BLSP4452.SGD","LU1023059063.AUD","LU0058720904.USD","BK4007","BK4599","SG9999002232.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","BK4568","BK4581","LU0289739699.SGD","BK7067","LU1883839398.USD","LU0306806265.USD","LU0122379950.USD","IE0002270589.USD","BK4534","BK4585","BK7508","BK4592","IE00B19Z3581.USD","LU0456855351.SGD","SGXZ57979304.SGD","SG9999013999.USD","LU0321505868.SGD","IE00BLSP4239.USD","LU0985481810.HKD","LU1066053197.SGD","BK4588","LU0306807586.USD","LU1066051498.USD","LU1894683348.USD","BK4550","SG9999002224.SGD","SG9999003800.SGD","BK7511","LU1894683264.USD","LU0225771236.USD"],"gpt_icon":0},{"id":"2620479392","title":"BRIEF-CSL Currently Experiencing Temporary Global Stockout Of HEMGENIX","url":"https://stock-news.laohu8.com/highlight/detail?id=2620479392","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620479392?lang=en_us&edition=fundamental","pubTime":"2026-03-17 23:50","pubTimestamp":1773762638,"startTime":"0","endTime":"0","summary":"BRIEF-CSL Currently Experiencing Temporary Global Stockout Of HEMGENIXMarch 17  - CSL Ltd CSL.AX:CSL IS CURRENTLY EXPERIENCING A TEMPORARY GLOBAL STOCKOUT OF HEMGENIXWORKING WITH REGULATORY AUTHORITIES ON STRATEGIES TO ENSURE STABLE ONGOING SUPPLY FOR HEMGENIXFurther company coverage: CSL.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nFWN4050QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","BK7508","CSL.AU","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":98,"code":"91000000","status":"200"}]}}